Seagen
Medicine
Pfizer Pouring COVID Profits into Cancer Battle, CEO Bourla Says
Pharmaceutical giant Pfizer is pouring the windfall profits from its COVID-19 vaccine into developing products to battle cancer, Chief Executive Albert Bourla said at a Reuters event on Thursday.
"Pfizer is giving all the profits that we made from COVID...
Business
Pfizer Announces $43 Billion Deal for Cancer Drug Innovator Seagen
Pharmaceutical giant Pfizer Inc. (PFE.N) has announced its intention to acquire Seagen Inc. (SGEN.O) in a $43 billion deal.
The acquisition is aimed at reinforcing Pfizer's portfolio of targeted cancer therapies in the face of an expected decline in sales...